Effectiveness of Isoniazid Treatment for Latent Tuberculosis Infection among Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Injection Drug Users in Methadone Programs
Open Access
- 15 December 2003
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 37 (12) , 1686-1692
- https://doi.org/10.1086/379513
Abstract
Injection drug users (IDUs) were heavily affected by the tuberculosis (TB) resurgence in New York City in the 1990s. We assessed the effectiveness ofKeywords
This publication has 18 references indexed in Scilit:
- The global tuberculosis situation: Progress and problems in the 20th century, prospects for the 21st centuryInfectious Disease Clinics of North America, 2002
- Hepatotoxicity Associated With Isoniazid Preventive TherapyJAMA, 1999
- A Trial of Three Regimens to Prevent Tuberculosis in Ugandan Adults Infected with the Human Immunodeficiency VirusNew England Journal of Medicine, 1997
- A Controlled Trial of Isoniazid in Persons with Anergy and Human Immunodeficiency Virus Infection Who Are at High Risk for TuberculosisNew England Journal of Medicine, 1997
- Incidence of Tuberculosis in the United States among HIV-Infected PersonsAnnals of Internal Medicine, 1997
- Tuberculosis in New York City — Turning the TideNew England Journal of Medicine, 1995
- Tuberculin Reactions Among Attendees at a Methadone Clinic: Relation to Infection with the Human Immunodeficiency VirusClinical Infectious Diseases, 1994
- Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infectionThe Lancet, 1993
- Tuberculosis in Patients with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1989